Published in Inflamm Bowel Dis on July 01, 2006
Inflammatory bowel disease. N Engl J Med (2009) 8.62
Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63
Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology (2011) 2.90
ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology (2010) 2.83
Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A (2010) 1.50
Inflammatory bowel disease: pathogenesis. World J Gastroenterol (2014) 1.26
Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis (2010) 1.22
Secretory mediators regulate Nod2-induced tolerance in human macrophages. Gastroenterology (2010) 1.13
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol (2008) 1.07
The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish. Dis Model Mech (2011) 1.04
Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One (2011) 1.03
Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med (Berl) (2011) 1.01
Inflammasomes and their activation. Crit Rev Immunol (2010) 0.98
Microbiota activation and regulation of innate and adaptive immunity. Immunol Rev (2014) 0.98
Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines. Gastroenterology (2012) 0.97
A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy. J Biol Chem (2012) 0.94
Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis. PLoS One (2012) 0.93
Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows Arch (2007) 0.90
Inflammasome-mediated autoinflammatory disorders. Postgrad Med (2010) 0.90
The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells. Gastroenterology (2012) 0.88
Respiratory involvement in inflammatory bowel diseases. Multidiscip Respir Med (2010) 0.86
Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease. BMC Gastroenterol (2010) 0.86
NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury. J Immunol (2014) 0.85
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease. RMD Open (2015) 0.84
Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol (2014) 0.82
Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature. Case Rep Dent (2015) 0.80
Single nucleotide polymorphisms in pathogen recognition receptor genes are associated with susceptibility to meningococcal meningitis in a pediatric cohort. PLoS One (2013) 0.80
Altered cytokine profiles of mononuclear cells after stimulation in a patient with Blau syndrome. Rheumatol Int (2010) 0.80
'Nodophagy': New crossroads in Crohn disease pathogenesis. Gut Microbes (2010) 0.79
The role of NOD2 in murine and human melioidosis. J Immunol (2013) 0.79
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam (2012) 0.79
Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort. CMAJ (2012) 0.78
Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol (2015) 0.77
Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol (2017) 0.75
Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial. J Gastroenterol (2015) 0.75
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet (2008) 9.52
Inflammatory bowel disease. N Engl J Med (2009) 8.62
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet (2011) 5.58
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65
The genetics of inflammatory bowel disease. Gastroenterology (2003) 2.95
L-histidine decarboxylase and Tourette's syndrome. N Engl J Med (2010) 2.92
Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology (2003) 2.64
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature (2012) 2.36
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet (2003) 2.33
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut (2011) 2.26
Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet (2004) 2.23
Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci U S A (2007) 2.20
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med (2009) 1.85
Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol (2006) 1.83
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol (2006) 1.79
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Unraveling the genetics of autoimmunity. Cell (2010) 1.51
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet (2007) 1.48
A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis (2004) 1.47
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis (2003) 1.42
Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet (2013) 1.34
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest (2004) 1.28
Improved risk prediction for Crohn's disease with a multi-locus approach. Hum Mol Genet (2011) 1.28
MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet (2003) 1.26
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis (2007) 1.26
A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis (2004) 1.21
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol (2012) 1.02
Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.00
The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis (2013) 0.96
Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol (2006) 0.92
Effector CD4+ T cell expression signatures and immune-mediated disease associated genes. PLoS One (2012) 0.91
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am J Hematol (2012) 0.90
Update on genetics of inflammatory bowel disease. Curr Opin Gastroenterol (2002) 0.89
Empirical Bayes correction for the Winner's Curse in genetic association studies. Genet Epidemiol (2012) 0.89
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis (2012) 0.88
Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis (2007) 0.88
A new approach for the joint analysis of multiple ChIP-seq libraries with application to histone modification. Stat Appl Genet Mol Biol (2012) 0.87
Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. Hum Mol Genet (2002) 0.86
Celiac disease in a child with ulcerative colitis: a possible genetic association. J Clin Gastroenterol (2013) 0.84
The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm Bowel Dis (2005) 0.84
Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases. Int J Colorectal Dis (2010) 0.82
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.82
Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells. PLoS One (2013) 0.81
Bugging of the intestinal mucosa. N Engl J Med (2007) 0.77
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study. Inflamm Bowel Dis (2016) 0.75
Inducing intestinal growth. N Engl J Med (2005) 0.75
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat Commun (2016) 0.75